Study timeline

Publication added by Petros Isaakidis

Standard versus double dose dolutegravir in patients with HIV-associated tuberculosis: a phase 2 non-comparative randomised controlled (RADIANT-TB) trial Griesel, Rulan – F1000 Research Ltd (2021)
4th May 2023 10:50
21st April 2023 10:39

Status Update Completion

2023

Protocol added by Petros Isaakidis

Dolutegravir_TB_phase_2_protocol_V1.2._MSF_ERB_REVISED_CLEAN.DOCX
Sign in to see preview
87.5 KB
10th February 2020 10:11

ERB documentation added by Petros Isaakidis

18109_MSFERB_Amendment_Approval_23June2019.pdf
Sign in to see preview
683 KB
10th February 2020 10:11

ERB documentation added by Petros Isaakidis

UCT_HREC_Protocol_amendment_approval_RADIANT-TB.pdf
Sign in to see preview
1.59 MB
10th February 2020 10:09
14th January 2020 13:36

Status Update Concept

2020